110 related articles for article (PubMed ID: 18338615)
21. Effects of automated external lubrication on tablet properties and the stability of eprazinone hydrochloride.
Yamamura T; Ohta T; Taira T; Ogawa Y; Sakai Y; Moribe K; Yamamoto K
Int J Pharm; 2009 Mar; 370(1-2):1-7. PubMed ID: 19059327
[TBL] [Abstract][Full Text] [Related]
22. Measuring the distribution of density and tabletting force in pharmaceutical tablets by chemical imaging.
Ellison CD; Ennis BJ; Hamad ML; Lyon RC
J Pharm Biomed Anal; 2008 Sep; 48(1):1-7. PubMed ID: 18539424
[TBL] [Abstract][Full Text] [Related]
23. [Preparation and in vitro release of ginkgo biloba extract sustained-release tablets].
Cui Q; Zhu Y; Cui J
Zhongguo Zhong Yao Za Zhi; 2009 Aug; 34(15):1910-3. PubMed ID: 19894532
[TBL] [Abstract][Full Text] [Related]
24. [Research on preparation of Shandantong sustained-release tablets].
Yuan WP; Liu LN; Wang M
Zhong Yao Cai; 2008 Oct; 31(10):1564-7. PubMed ID: 19230418
[TBL] [Abstract][Full Text] [Related]
25. Powder for reconstitution of the anti-HIV-1 drug TMC278 - Formulation development, stability and animal studies.
Van Gyseghem E; Pendela M; Baert L; Rosier J; Van 't Klooster G; De Man H; Bouche MP; Schueller L; Van Remoortere P; Wigerinck P; Adams E; Hoogmartens J; Van den Mooter G
Eur J Pharm Biopharm; 2008 Nov; 70(3):853-60. PubMed ID: 18657611
[TBL] [Abstract][Full Text] [Related]
26. [Study on preparation and release mechanism of effervescent osmotic pump tablet of compound Danshen].
Xue L; Li Y; Guo D; Yin J; Liu Y; Hou S
Zhongguo Zhong Yao Za Zhi; 2009 Apr; 34(7):848-51. PubMed ID: 19623978
[TBL] [Abstract][Full Text] [Related]
27. Formulation of intelligent tablets with an antacid effect.
Bajdik J; Korbely A; Pintye-Hódi K
Pharm Dev Technol; 2009; 14(5):471-5. PubMed ID: 19552554
[TBL] [Abstract][Full Text] [Related]
28. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
29. Influence of polymeric subcoats on the drug release properties of tablets powder-coated with pre-plasticized Eudragit L 100-55.
Sauer D; Watts AB; Coots LB; Zheng WC; McGinity JW
Int J Pharm; 2009 Feb; 367(1-2):20-8. PubMed ID: 18848872
[TBL] [Abstract][Full Text] [Related]
30. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.
Javadzadeh Y; Musaalrezaei L; Nokhodchi A
Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643
[TBL] [Abstract][Full Text] [Related]
31. [Preparation and properties of sustained-release pellets of glycyrrhizin effective components].
Chen LH; Feng Y; Xu DS; Li JS; Zhang L; Wang YH
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):509-13. PubMed ID: 18536370
[TBL] [Abstract][Full Text] [Related]
32. Material and tablet properties of pregelatinized (thermally modified) Dioscorea starches.
Odeku OA; Schmid W; Picker-Freyer KM
Eur J Pharm Biopharm; 2008 Sep; 70(1):357-71. PubMed ID: 18562187
[TBL] [Abstract][Full Text] [Related]
33. A review of co-processed directly compressible excipients.
Gohel MC; Jogani PD
J Pharm Pharm Sci; 2005 Apr; 8(1):76-93. PubMed ID: 15946601
[TBL] [Abstract][Full Text] [Related]
34. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
[TBL] [Abstract][Full Text] [Related]
35. [Preparation of tetrandrine alginate calcium sustained release gel pellets].
Ma Y; Li WZ; Chen DW
Zhong Yao Cai; 2008 Jan; 31(1):131-4. PubMed ID: 18589765
[TBL] [Abstract][Full Text] [Related]
36. [[Preparation of sucking tablet of shengmei] off].
Jiang J; Shao J; Zhu Z; Dai Y; Xu C
Zhongguo Zhong Yao Za Zhi; 1992 Jun; 17(6):346-8, 383. PubMed ID: 1418578
[TBL] [Abstract][Full Text] [Related]
37. The robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticles.
Nilkumhang S; Basit AW
Int J Pharm; 2009 Jul; 377(1-2):135-41. PubMed ID: 19515519
[TBL] [Abstract][Full Text] [Related]
38. Oral matrix tablet formulations for concomitant controlled release of anti-tubercular drugs: design and in vitro evaluations.
Hiremath PS; Saha RN
Int J Pharm; 2008 Oct; 362(1-2):118-25. PubMed ID: 18640251
[TBL] [Abstract][Full Text] [Related]
39. Systematical approach of formulation and process development using roller compaction.
Teng Y; Qiu Z; Wen H
Eur J Pharm Biopharm; 2009 Oct; 73(2):219-29. PubMed ID: 19406236
[TBL] [Abstract][Full Text] [Related]
40. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers.
Li X; Nie SF; Kong J; Li N; Ju CY; Pan WS
Int J Pharm; 2008 Nov; 363(1-2):177-82. PubMed ID: 18706987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
